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ABSTRACT 
Diffuse thrombosis of the entire portal system (PVT) and cavernomatous transformation of the 
portal vein (CTPV) represents a demanding challenge in liver transplantation. We present the 
case of a patient with nodular regenerative hyperplasia and recurrent episodes of type B hepatic 
encephalopathy concomitant with PVT as well as CTPV, successfully treated with orthotopic 
liver transplantation. The portal inflow to the graft was carried out through the confluence of 2 
thin paracholedochal varicose veins, obtaining good early graft function and recovery of the 
encephalopatic episodes. This alternative should be kept in mind as an option to assure 
hepatopetal splanchnic flow in those cases of diffuse thrombosis and cavernomatous 
transformation of portal vein. 
HT E COMPLICATIONS of diffuse portal-splenic and superior mesenteric vein thrombosis 
(PVT) with subsequent cavernous transformation of the portal vein (CTPV) in noncirrhotic 
patients represent a clinical challenge. When the medical and interventional procedures fail, liver 
transplantation (OLT) or combined liver–small bowel transplantation remain the ultimate 
option.1,2 Although several surgical alternatives have been described to overcome PVT and CTPV 
in clinical series, the absence of portal flow remains a challenge in OLT, for it increases the 
morbidity and mortality of the procedure.3,4 Herein we have presented a case of a successful OLT 
in a patient with PVT and CTPV. The portal inflow of the graft was achieved through the 
confluence of two pericholedochal veins (Petren’s veins). 
CASE REPORT 
A 54-year-old man with complete thrombosis of the portal vein and nodular regenerative 
hyperplasia (NRH) was referred for a transjugular intrahepatic portosystemic shunt (TIPS) 
procedure. The diagnosis of PVT due to antiphospholipid antibody syndrome had been previously 
established during 2 episodes of abdominal pain. Doppler ultrasound and computed tomography 
confirmed the PVT diagnosis. The patient later developed esophageal varices and bled on 3 
ocasions despite /3-blocker administration, requiring sclerotherapy sessions. 
Six months after the TIPS procedure, he suffered several episodes of portosystemic 
encephalopathy (PSE). The patient was treated with conservative medical therapy, administration 
of lactulose nonabsorbable antibiotics, and a low-protein diet. However, the encephalopathy 
symptoms persisted, and he underwent an endovascular shunt reduction without clinical 
improvement.5 OLT was indicated due to the progressively debilitating PSE. 
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Transplant Procedure 
OLT was performed using an 80-year-old isogroup ABO graft from a cadaveric donor. The 
complete portal vein thrombosis including a prior stent, extended to the superior mesenteric vein and 
splenic vein with cavernous transformation of the portal vein. After meticulous dissection of the 
liver hilum, we identified 2 thin-walled pericholedochal varices above the pancreas, which we 
formed into a common cloaca with a venoplasty at their confluence (Fig 1). 
Despite the piggy-back technique, the native hepatectomy was technically demanding because of 
the presence of vascular adhesions.6 We ligated the recipient portal vein, which was replaced by a 
fibrotic, thrombosed cord. After completing the suprahepatic anastomosis in the usual fashion, the 
arterial inflow to the new liver was provided by an end-to-lateral anastomosis between the donor 
celiac axis and the recipient common hepatic artery. Once the liver was reperfused through the 
hepatic artery, an end-to-end portal anastomosis was constructed between the donor and common 
cloaca formed by the confluence of 2 pericholedochal veins, using a running suture of 6/0 Prolene, 
leaving a large growth factor of 1 cm. At the end of the procedure, arterial and portal flow were 
300 and 800 mL/min, respectively (Medi-stim Butterfly Flowmeter. Medi-stim AS. 
The patient experienced an uneventful postoperative outcome. Two postoperative Doppler 
ultrasound tests showed the patency and adequate flow in the hepatic artery and portal vein. The 
pathology report of the native liver confirmed the diagnosis of NRH with a chronic organized 
portal thrombosis containing an endothelialized partially patent Wallstent prosthesis. The patient 
was treated with prophylactic low-molecular-weight heparin and acetylsalicylic acid. He 
recovered from encephalopathy and has remained asymptomatic for 20 months posttransplant. 
DISCUSSION 
Complete thrombosis of the portal and splenomesenteric veins combined with cavernous 
transformation of the portal vein represents a surgically demanding challenge in the setting of 
OLT.4 Portal reconstruction in this setting needs to decrease portal hypertension, provide adequate 
“portal” flow to the liver and, as a consequence, and reestablish hepatic metabolism of ammonia 
produced in the gut. Various alternatives have been reported to overcome PVT, including 
cavoportal hemitransposition (CPHT), renoportal anastomosis (RPA), and portal 
arterialization.3,4,7 Other authors have reported combined liver-intestinal transplantation with a 3-
year survival rate around 60%.2
In our case, we decided to perform an end-to-end portal anastomosis to the confluence of 2 thin-
walled paracholedochal collateral veins, which provided adequate early portal inflow (800 
mL/min). 
The formation of a fine reticular epicholedochal venous plexus in intimate contact with the 
paracholedochal veins (known as Petren’s veins) of the common bile duct has previously been 
reported in the setting of complete PVT.8,9
In 1986, Hiatt et al9 described for the first time the use of a thin-walled varix as the inflow to the 
donor portal vein. The varix was identified inferolateral to the common bile duct just above the 
pancreas. The anastomosis remained patent after an 8-year follow-up. 
The technique described herein for reconstruction of graft portal flow, (when possible,) offers 
advantages over the other previously mentioned options to reconstruct portal flow with systemic 
blood flow. In subjects undergoing CPHT and RPA, persistent portal hypertension has been 
described with the ongoing risks of bleeding, which occurred in 37% of reported cases, as well as 
of hepatic encephalopathy. Long-term effects of systemic venous flow to the graft are still 
unknown. 
In contrast, hepatotrophic factors that originate in the intestines and pancreas are present in the 
portal inflow to the liver is very well established, suggesting the benefit of maintaining the 
splanchnic drainage through the liver to avoid neuropathologic consequences of a portosystemic 
shunt, as occurred in our patient secondary to the TIPS procedure before transplantation.10
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Fig 1. Schematic of CTPV found at surgery and paracholedochal 
varices and donor portal anastomosis. SMV, superior mesenteric 
vein; IMV, inferior mesenteric vein; SV, splenic vein; LGF, left 
gastric vein. 
 
 
 
 
 
